Annual Drug Patent Expirations for PREZISTA
Prezista is a drug marketed by Janssen Prods and is included in two NDAs. It is available from one supplier. There are two patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for PREZISTA.
The generic ingredient in PREZISTA is darunavir. One supplier is listed for this compound. Additional details are available on the darunavir profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com